(Reuters) – Drugmaker Insys Therapeutics Inc on Thursday received courtroom approval to promote its flagship fentanyl spray to a purchaser who agreed to solely market the drug to be used by most cancers sufferers, in response to considerations concerning the product’s position in fueling the opioid epidemic.

FILE PHOTO: A field of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc. U.S. Legal professional’s Workplace for the Southern District of Alabama/by way of REUTERS

The choice by U.S. Chapter Choose Kevin Gross in Wilmington, Delaware, marked the primary time a chapter courtroom authorized the sale of an opioid amid an epidemic that has been blamed for practically 400,000 overdose…

Source link